Bruker Corp (BRKR)
57.08
+0.86
(+1.52%)
USD |
NASDAQ |
Nov 22, 16:00
57.08
0.00 (0.00%)
After-Hours: 20:00
Bruker Revenue (Annual): 2.964B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.964B |
| December 31, 2022 | 2.531B |
| December 31, 2021 | 2.418B |
| December 31, 2020 | 1.988B |
| December 31, 2019 | 2.073B |
| December 31, 2018 | 1.896B |
| December 31, 2017 | 1.766B |
| December 31, 2016 | 1.611B |
| December 31, 2015 | 1.624B |
| December 31, 2014 | 1.809B |
| December 31, 2013 | 1.839B |
| December 31, 2012 | 1.791B |
| December 31, 2011 | 1.652B |
| Date | Value |
|---|---|
| December 31, 2010 | 1.305B |
| December 31, 2009 | 1.114B |
| December 31, 2008 | 1.107B |
| December 31, 2007 | 1.032B |
| December 31, 2006 | 435.83M |
| December 31, 2005 | 372.25M |
| December 31, 2004 | 356.99M |
| December 31, 2003 | 260.68M |
| December 31, 2002 | 220.66M |
| December 31, 2001 | 175.28M |
| December 31, 2000 | 76.60M |
| December 31, 1999 | 64.69M |
| December 31, 1998 | 42.21M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
1.988B
Minimum
2020
2.964B
Maximum
2023
2.395B
Average
2.418B
Median
2021
Revenue (Annual) Benchmarks
| Azenta Inc | 656.32M |
| Harvard Bioscience Inc | 112.25M |
| Bionano Genomics Inc | 36.12M |
| Akoya Biosciences Inc | 96.63M |
| Singular Genomics Systems Inc | 2.911M |